Drug Discovery Services Market : Trends & Forecasts upto 2025

  • September 24, 2018
  • 300
  • ICT & Media

New York City, NY, 24 September, 2018/24 Market Reports:This report studies the global Drug Discovery Services market, analyzes and researches the Drug Discovery Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

As a result, players offering novel in silico drug discovery services, such as CADD, have now become an integral part of the pharmaceutical industry. According to industry experts, almost 30% of the total cost and time invested in developing a new drug can be saved by utilizing such services. Owing to the significant cost benefits offered by such approaches, the adoption of CADD is anticipated to increase in the coming years. Furthermore, the growing number of drug discovery projects, coupled to their rapid progression through various stages of drug discovery, is expected to continue to create an increasing demand for computational services.

Drug Discovery Services Market Key Segment

 

Global Drug Discovery Services Market By Players:

  • Albany Molecular Research Inc (AMRI) (US)
  • Charles River Laboratories International (US)
  • Evotec (Germany)
  • GenScript (US)
  • Covance (US)
  • WuXi AppTec (China)
  • Pharmaceutical Product Development (PPD) (US)
  • Jubilant Biosys (India)
  • GE Healthcare (US)
  • Merck (Germany)
  • Piramal Enterprises (India)
  • Advinus Therapeutics (India)

Global Drug Discovery Services Market By Regions/Countries:

  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia

Global Drug Discovery Services Market By Type:

  • Small Molecules
  • Biologics

Global Drug Discovery Services Market By Application:

  • Medicinal Chemistry
  • Biology Services
  • DMPK

Get the Complete Report & TOC @ https://www.24marketreports.com/ict-and-media/global-drug-discovery-services-market-size-status-and-forecast-2025

 

close

categories